Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Erin Foran Wolff, Jan Lötvall, Tom Willardson, and John Monroe

Erin Foran Wolff

Celmatix has appointed Erin Foran Wolff as its first chief medical officer. She will play an important role as the company prepares to launch its first genetic test and continues to scale its analytics platform, Polaris, already in use at leading fertility clinics across the US. Wolff comes to Celmatix from the National Institutes of Health, where she worked as an assistant clinical investigator and conducted basic, translational, and clinical reproductive research.


Jan Lötvall

Codiak BioSciences has appointed Jan Lötvall as chief scientist. Lötvall will report to Douglas Williams, president and CEO, and he will begin his new position this summer. Lötvall joins Codiak from Göteborg University, where he served as professor of allergy since 2002, and as chairman of the Krefting Research Center. This month he also completed his term as the first elected president of the International Society of Extracellular Vesicles, which he helped start in 2011. From 1988, to 1990, he was a fellow at the Department of Thoracic Medicine at Imperial College London, and from 1997 to 1998, he was a visiting professor in the Department of Respiratory Medicine at McMaster University in Canada.

Tom Willardson and John Monroe

Mesa Biotech has appointed Tom Willardson as CFO and John Monroe as senior vice president of operations. Willardson has more than 30 years of industry experience in large global companies and early-stage startups, while Monroe has 20 years of lateral flow manufacturing experience at Quidel and Alere.


For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more